Author:
Koo Kevin M.,Wee Eugene J. H.,Mainwaring Paul N.,Trau Matt
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Schroder, F. H. et al. Prostate-Cancer Mortality at 11 Years of Follow-up. N. Eng. J. Med. 366, 981–990 (2012).
2. Prensner, J. R., Rubin, M. A., Wei, J. T. & Chinnaiyan, A. M. Beyond PSA: The next generation of prostate cancer biomarkers. Science Transl. Med. 4, 127rv3 (2012).
3. Cuzick, J. et al. Prevention and early detection of prostate cancer. Lancet Oncol. 15, E484–E492 (2014).
4. Andriole, G. L. et al. Prostate cancer screening in the randomized prostate, lung, colorectal and ovarian cancer screening trial: Mortality results after 13 Years of follow-up. J. Natl. Cancer Inst. 104, 125–132 (2012).
5. Shoag, J. et al. Efficacy of prostate-specific antigen screening: Use of regression discontinuity in the PLCO cancer screening trial. JAMA Oncol. 1, (2015).